Corvus Pharmaceuticals CRVS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's free cash flow?
- Corvus Pharmaceuticals (CRVS) reported free cash flow of -$10.47M in Q1 2026.
- How has Corvus Pharmaceuticals's free cash flow changed year-over-year?
- Corvus Pharmaceuticals's free cash flow decreased by 26.1% year-over-year, from -$8.3M to -$10.47M.
- What is the long-term trend for Corvus Pharmaceuticals's free cash flow?
- Over 2 years (2021 to 2025), Corvus Pharmaceuticals's free cash flow has grown at a -5.2% compound annual growth rate (CAGR), from -$36.72M to -$32.97M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.